secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001193125-26-048736
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin closes $850M 5.500% senior notes offering to fund Amicus acquisition
-----------------------------------------------------------------------------

- Closed private placement of $850M 5.500% senior notes due 2034 at 100% issue price.
- Net proceeds, combined with $2B term loan B, $800M term loan A, and cash, to fund Amicus acquisition.
- Notes held in escrow; if acquisition not completed by Dec 19, 2026, notes redeemed at par plus accrued interest.
- Notes guaranteed by certain subsidiaries; after closing, Amicus and its subsidiaries will also guarantee.
- Expects to enter $600M senior secured revolving credit facility in connection with the acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312526048736/0001193125-26-048736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312526048736/d63881d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-048736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer